HCPCS Level IIdrugActive
J9196
Inj gemcitabine hcl (accord)
BETOS: O1D
Effective: 2024-01-01
Description
Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Gemcitabine
Manufacturer
Accord Healthcare Inc
HCPCS Dosage
200 MG
Billing Units
1.0000
7
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.